All Set For EU Approval: First Biosimilar Humalog And Three More Rituximabs From Celltrion

 
• By Ian Schofield and Maureen Kenny
Diabetes
The EU's CHMP has OKd the first biosimilar version of Lilly's antidiabetic Humalog

More from Biosimilars

More from Biosimilars & Generics